SARS-CoV-2 and COVID-19

Submitted by galeadmin on Tue, 05/26/2020 - 12:21

The Gale Laboratory is actively engaged in the local and national response to SARS-CoV-2 infection and COVID-19 disease, and is collaborating with our international colleagues to support the global response to control and prevent SARS-CoV-2 infection. Our efforts include conducting antibody testing to determine community exposure frequency to SARS-CoV-2, assessing SARS-CoV-2 infection and virus replication in culture, and defining the innate immune and inflammatory programs that are triggered and regulated by SARS-CoV-2 infection to impart COVID-19 disease outcome.

For updates on local and global COVID-19 status, the following resources are available:

Dr. Caleb Stokes awarded NIAID Clinical Scientist Research Career Development K08 Award.

Submitted by galeadmin on Fri, 05/22/2020 - 12:55

Caleb Stokes, MD, PhD. Has been awarded a K08 grant from NIH/NIAID to support the development of his independent research program defining the processes of innate immunity that control virus infection in the central nervous system. Focusing on Zika virus infection in human induced neural progenitor cells, his K08 award work aims to determine how innate immunity directs the outcome Zika virus infection in the developing brain.

Dr. Katherine Wuertz completes her dissertation and returns to the US Army as Major

Submitted by galeadmin on Thu, 04/02/2020 - 12:06

Data Stories | Understanding STING

See how researcher Kathryn McGuckin Wuertz is trying to understand the relationship between infectious diseases and neurological diseases

Kathryn McGuckin Wuertz is trying to understand the relationship between infectious diseases and neurological diseases. McGuckin Wuertz is a Major in the U.S. Army stationed at Walter Reed Army Institute of Research in Maryland.

Dr. Hemann has been awarded an NIAID K22 career transition award

Submitted by galeadmin on Fri, 03/06/2020 - 09:36

Influenza virus infection causes significant illness and death globally each year despite the existence of a vaccine. Our work has sought to understand the innate immune determinates that are able to regulate the induction of protective adaptive immune responses against influenza in order to inform novel therapeutic and adjuvant strategies. We recently published a study revealing that the innate immune cytokine IFN-lambda acts on DC and is required for generation of optimal CD8 T cell-mediated protection against influenza virus infection in a murine model (DOI:10.1038/s41590-019-0408-z).

Save the Date! On November 1-4, 2020, the International Cytokine and Interferon Society (ICIS) will be hosting its 8th annual meeting Cytokines 2020: Structure-Function and Systems Biology of Cytokines

Submitted by galeadmin on Thu, 12/12/2019 - 10:02


After careful consideration the ICIS and Seattle 2020 meeting leadership have decided to make Cytokines 2020 an all virtual meeting.  This difficult decision is based upon the uncertainty of SARS-CoV-2 exposure outcome from holding an in-person gathering in Seattle.


For multiple years the Gale Lab continues as one of the most highly cited laboratories in infectious disease and immunology research in the world.

Submitted by galeadmin on Wed, 12/11/2019 - 10:57

This highly anticipated annual list identifies scientists who produced multiple papers ranking in the top 1% by citations for their field and year of publication, demonstrating significant research influence among their peers. Read more about the methodology here.